Rui M. Lopes

601 total citations
16 papers, 437 citations indexed

About

Rui M. Lopes is a scholar working on Public Health, Environmental and Occupational Health, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, Rui M. Lopes has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Pharmaceutical Science and 4 papers in Organic Chemistry. Recurrent topics in Rui M. Lopes's work include Research on Leishmaniasis Studies (6 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Rui M. Lopes is often cited by papers focused on Research on Leishmaniasis Studies (6 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Rui M. Lopes collaborates with scholars based in Portugal, Greece and United Kingdom. Rui M. Lopes's co-authors include António J. Almeida, M.E.M. Cruz, Lídia Gonçalves, Carla Eleutério, M. Luísa Corvo, Manuela Carvalheiro, Effie Scoulica, M.B.F. Martins, M. Alexandra Esteves and Cecília R. C. Calado and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Rui M. Lopes

15 papers receiving 423 citations

Peers

Rui M. Lopes

PHEOH

BIOMA

Jorge Montanari Argentina

Carol Yousry Egypt

Elham Abdelmonem Mohamed Egypt

Sadek Ahmed Egypt

Marcelle Silva-Abreu Spain

Cristina G. Venturini Brazil

Kaushalkumar Dave United States

Taylor L. Carlson United States

M Ahmed Egypt

Menna M. Abdellatif Egypt

Jorge Montanari Argentina

Rui M. Lopes

165 ×1.1

203 ×1.6

104 ×1.2

PHEOH

94 ×1.3

BIOMA

73 ×1.3

Citations per year, relative to Rui M. Lopes Rui M. Lopes (= 1×) peers Jorge Montanari

Countries citing papers authored by Rui M. Lopes

Since Specialization

Citations

This map shows the geographic impact of Rui M. Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui M. Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui M. Lopes more than expected).

Fields of papers citing papers by Rui M. Lopes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui M. Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui M. Lopes. The network helps show where Rui M. Lopes may publish in the future.

Co-authorship network of co-authors of Rui M. Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Rui M. Lopes. A scholar is included among the top collaborators of Rui M. Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui M. Lopes. Rui M. Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lopes, Rui M., et al.. (2024). Saúde mental e transtorno do espectro autista: abordagens e desafios. Cuadernos de Educación y Desarrollo. 16(10). e5952–e5952. 1 indexed citations

Lopes, Rui M., Corinna Schlosser, Manjunath S. Shet, et al.. (2022). Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. International Journal of Pharmaceutics. 618. 121658–121658. 14 indexed citations

Pyrć, Krzysztof, Aleksandra Milewska, Emilia Barreto-Durán, et al.. (2021). SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray. Scientific Reports. 11(1). 20012–20012. 41 indexed citations

Lopes, Rui M., Kevin Shi, Nuno A. Fonseca, et al.. (2021). Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin. Drug Delivery and Translational Research. 12(3). 629–646. 11 indexed citations

Carvalheiro, Manuela, M. Alexandra Esteves, Rui M. Lopes, et al.. (2015). Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections. European Journal of Pharmaceutics and Biopharmaceutics. 93. 346–352. 17 indexed citations

Lopes, Rui M., M. Alexandra Esteves, Maria Manuela Gaspar, et al.. (2015). Lipid-Based Nanoformulations of Trifluralin Analogs in the Management ofLeishmania InfantumInfections. Nanomedicine. 11(2). 153–170. 15 indexed citations

Lopes, Rui M., et al.. (2015). Lecithin and parabens play a crucial role in tripalmitin‐based lipid nanoparticle stabilization throughout moist heat sterilization and freeze‐drying. European Journal of Lipid Science and Technology. 117(12). 1947–1959. 21 indexed citations

Durán‐Lobato, Matilde, Lucía Martín‐Banderas, Rui M. Lopes, et al.. (2015). Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility. Drug Development and Industrial Pharmacy. 42(2). 190–198. 36 indexed citations

Lopes, Rui M., Maria Manuela Gaspar, Carla Eleutério, et al.. (2014). Liposomes versus Lipid Nanoparticles: Comparative Study of Lipid-Based Systems as Oryzalin Carriers for the Treatment of Leishmaniasis. Journal of Biomedical Nanotechnology. 10(12). 3647–3657. 31 indexed citations

10.

Corvo, M. Luísa, H. Susana Marinho, Paulo Marcelino, et al.. (2014). Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity. Pharmaceutical Research. 32(1). 91–102. 30 indexed citations

11.

Lopes, Rui M., M. Luísa Corvo, Carla Eleutério, et al.. (2012). Formulation of oryzalin (ORZ) liposomes: In vitro studies and in vivo fate. European Journal of Pharmaceutics and Biopharmaceutics. 82(2). 281–290. 14 indexed citations

12.

Larachi, Faı̈çal, et al.. (2012). Multiphase reacting flow studies of bubble column ozonation reactor for water remediation. Chemical Engineering & Technology. 36(1). 137–146. 6 indexed citations

13.

Cadete, Ana, Lígia Figueiredo, Rui M. Lopes, et al.. (2011). Development and characterization of a new plasmid delivery system based on chitosan–sodium deoxycholate nanoparticles. European Journal of Pharmaceutical Sciences. 45(4). 451–458. 45 indexed citations

14.

Lopes, Rui M., Carla Eleutério, Lídia Gonçalves, M.E.M. Cruz, & António J. Almeida. (2011). Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. European Journal of Pharmaceutical Sciences. 45(4). 442–450. 81 indexed citations

15.

Esteves, M. Alexandra, et al.. (2009). Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents. Bioorganic & Medicinal Chemistry. 18(1). 274–281. 22 indexed citations

16.

Simões, Sandra, Teresa C. Delgado, Rui M. Lopes, et al.. (2005). Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes. Journal of Controlled Release. 103(2). 419–434. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact